Two research scientists, involved with the synthesis of a compound which formed the basis of a patented heart imaging agent, brought what is the first ever successful action under Section 40 of the Patents Act 1977, arguing that the patents are of outstanding benefit to their employer, and as such, they are entitled to a fair share of this benefit. The Court concluded that the patents had been of outstanding benefit and having valued the benefit as in the order of GBP 50,000,000 awarded GBP 1,000,000 to the 1st Claimant and GBP 500,000 to the 2nd Claimant on the basis that: ‘The benefits [of the patent] went far beyond anything which one could normally expect to arise from the sort of work the employees were doing’.

The full summary of this case has been posted on Kluwer IP Law.


To make sure you do not miss out on regular updates from the Kluwer Patent Blog, please subscribe here.

Kluwer IP Law

The 2022 Future Ready Lawyer survey showed that 79% of lawyers think that the importance of legal technology will increase for next year. With Kluwer IP Law you can navigate the increasingly global practice of IP law with specialized, local and cross-border information and tools from every preferred location. Are you, as an IP professional, ready for the future?

Learn how Kluwer IP Law can support you.

Kluwer IP Law
This page as PDF